Weber, Jeffrey S <br/><br/>
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.  [electronic resource] 

 -  Cancer  Sep 2009 
 - 3944-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.24473  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cytokines--analysis<br/>Dacarbazine--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Skin Neoplasms--drug therapy<br/>Survival Analysis<br/>Treatment Outcome